Astec LifeSciences Ltd Q1 FY25 consolidated loss at Rs. 39.72 crores

Astec LifeSciences Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 70.2962 crores during the period ended June 30, 2024 as compared to Rs. 155.7955 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. -39.7246 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. -0.9739 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. -20.26 for the period ended June 30, 2024 as compared to Rs. -0.50 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 70.2962 crs	₹155.7955 crs	-54.88%
Net Profit	₹-39.7246 crs	₹-0.9739 crs	3,978.92%
EPS	₹-20.26	₹-0.50	3,952.00%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 70.2962 crores during the period ended June 30, 2024 as compared to Rs.144.5572 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.-39.7246 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.-8.1946 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.-20.26 for the period ended June 30, 2024 as compared to Rs.-4.18 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 70.2962 crs	₹144.5572 crs	-51.37%
Net Profit	₹-39.7246 crs	₹-8.1946 crs	384.77%
EPS	₹-20.26	₹-4.18	384.69%

Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1272.00 as compared to the previous close of Rs. 1282.65. The total number of shares traded during the day was 2832 in over 564 trades.

The stock hit an intraday high of Rs. 1328.95 and intraday low of 1259.90. The net turnover during the day was Rs. 3657462.00.

Source : Equity Bulls

Keywords

AstecLifeSciences Q1FY25 FY2025 Q1FY2025 ResultUpdate